Showing 1 - 3 of 3
Pfizer offers to sell medicines at cost to poorest countries
AFP, Published on 25/05/2022
» DAVOS (SWITZERLAND) - US pharmaceutical giant Pfizer on Wednesday said it would sell its patented drugs on a not-for-profit basis to the world's poorest countries, as part of a new initiative announced at the World Economic Forum in Davos.
Nerve disorder listed as 'very rare' side effect of AstraZeneca vaccine
AFP, Published on 09/09/2021
» THE HAGUE: The European Medicines Agency has listed the neurological disorder Guillain-Barre syndrome, which can cause temporary paralysis, as a "very rare" side effect of the AstraZeneca Covid-19 vaccine.
'Increased risk' of rare nerve disorder after J&J Covid vaccine: US
AFP, Published on 13/07/2021
» WASHINGTON: The US Food and Drug Administration updated its warning labels Monday for the Johnson & Johnson Covid-19 vaccine to include information about an observed "increased risk" of a rare neurological disorder called Guillain-Barre Syndrome (GBS).